TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says February 19, 1993